235 related articles for article (PubMed ID: 35464439)
1. D-Mannose Regulates Hepatocyte Lipid Metabolism
Hu M; Chen Y; Deng F; Chang B; Luo J; Dong L; Lu X; Zhang Y; Chen Z; Zhou J
Front Immunol; 2022; 13():877650. PubMed ID: 35464439
[TBL] [Abstract][Full Text] [Related]
2. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
3. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
[TBL] [Abstract][Full Text] [Related]
4. The Regulation of Lipid Deposition by Insulin in Goose Liver Cells Is Mediated by the PI3K-AKT-mTOR Signaling Pathway.
Han C; Wei S; He F; Liu D; Wan H; Liu H; Li L; Xu H; Du X; Xu F
PLoS One; 2015; 10(5):e0098759. PubMed ID: 25945932
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibiting PI3K-Akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes.
Liu DD; Han CC; Wan HF; He F; Xu HY; Wei SH; Du XH; Xu F
Animal; 2016 Aug; 10(8):1319-27. PubMed ID: 26956906
[TBL] [Abstract][Full Text] [Related]
6. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
[TBL] [Abstract][Full Text] [Related]
7. Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.
Zhang Z; Wen H; Weng J; Feng L; Liu H; Hu X; Zeng F
Cell Cycle; 2019 Sep; 18(18):2239-2254. PubMed ID: 31378124
[TBL] [Abstract][Full Text] [Related]
8. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
[TBL] [Abstract][Full Text] [Related]
9. Hepatic-Metabolic Activity of α-Lipoic Acid-Its Influence on Sphingolipid Metabolism and PI3K/Akt/mTOR Pathway in a Rat Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Sztolsztener K; Chabowski A
Nutrients; 2024 May; 16(10):. PubMed ID: 38794739
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway.
Chen X; Bian M; Zhang C; Kai J; Yao Z; Jin H; Lu C; Shao J; Chen A; Zhang F; Zheng S
Biomed Pharmacother; 2018 Jan; 97():975-984. PubMed ID: 29136776
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 alleviates alcohol-associated hepatic fibrosis, inhibits autophagy, and suppresses the PI3K/AKT/mTOR pathway in mice.
Meng YX; Zhao R; Huo LJ
Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):448-458. PubMed ID: 36799106
[TBL] [Abstract][Full Text] [Related]
13. Dietary supplementation of salidroside alleviates liver lipid metabolism disorder and inflammatory response to promote hepatocyte regeneration via PI3K/AKT/Gsk3-β pathway.
Cui Z; Jin N; Amevor FK; Shu G; Du X; Kang X; Ning Z; Deng X; Tian Y; Zhu Q; Wang Y; Li D; Zhang Y; Wang X; Han X; Feng J; Zhao X
Poult Sci; 2022 Sep; 101(9):102034. PubMed ID: 35926351
[TBL] [Abstract][Full Text] [Related]
14. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
15. Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade.
He Y; Wang H; Lin S; Chen T; Chang D; Sun Y; Wang C; Liu Y; Lu Y; Song J; Li S; Xu W; Lin Y; Zheng Y; Zhou X; Huang Q; Huang M
Biomed Pharmacother; 2023 Sep; 165():115279. PubMed ID: 37544281
[TBL] [Abstract][Full Text] [Related]
16. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
[TBL] [Abstract][Full Text] [Related]
17. Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway.
Li CH; Tang SC; Wong CH; Wang Y; Jiang JD; Chen Y
Eur J Pharmacol; 2018 Apr; 825():107-118. PubMed ID: 29477657
[TBL] [Abstract][Full Text] [Related]
18. HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.
Chen J; Chen J; Huang J; Li Z; Gong Y; Zou B; Liu X; Ding L; Li P; Zhu Z; Zhang B; Guo H; Cai C; Li J
Aging (Albany NY); 2019 Dec; 11(23):10839-10860. PubMed ID: 31796646
[TBL] [Abstract][Full Text] [Related]
19. Insulin Stimulates Goose Liver Cell Growth by Activating PI3K-AKT-mTOR Signal Pathway.
Han C; Wei S; Song Q; He F; Xiong X; Wan H; Liu D; Ye F; Liu H; Li L; Xu H; Du X; Kang B; Zeng X
Cell Physiol Biochem; 2016; 38(2):558-70. PubMed ID: 26845041
[TBL] [Abstract][Full Text] [Related]
20. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling.
Teng F; Jiang J; Zhang J; Yuan Y; Li K; Zhou B; Zhou X; Liu W; Zhang P; Liu D; Zheng M; Lu Y; Zhang H
Metabolism; 2021 Apr; 117():154725. PubMed ID: 33571540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
